Acadia Expands its License Agreement with Neuren to Acquire Ex-North American Rights to Trofinetide and Global Rights to NNZ-2591
July 14, 2023
Insights+: The US FDA New Drug Approvals in March 2023
April 19, 2023
Acadia Reports the NDA Submission of Trofinetide to the US FDA for the Treatment of Rett Syndrome
July 19, 2022
Acadia Collaborated with Stoke to Develop and Commercialize RNA-Based Therapies for Rare Genetic Neurodevelopmental Diseases
January 11, 2022
ACADIA Acquires CerSci Therapeutics for $52.5M
August 26, 2020
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.